Indoco Remedies Limited
Live Market Data
About Company
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
Industry Segment
Price Chart
Technical Analysis
Technical Outlook
Valuation Check
Research Reports
Peer Comparison
Related Sector| Company | Price | P/E | M.Cap (Cr) | ROE % |
|---|---|---|---|---|
FDC LIMITED FDC | ₹319.95 | 24.07 | 5,209 | - |
J B CHEMICALS AND PHARMA JBCHEPHARM | ₹2,063.5 | 43.43 | 33,131 | - |
SHILPA MEDICARE LTD SHILPAMED | ₹349.05 | 30.92 | 6,828 | - |
IPCA LABORATORIES LTD IPCALAB | ₹1,594.5 | 44.49 | 40,600 | - |
HIKAL LIMITED HIKAL | ₹156.4 | - | 1,929 | - |
Quarterly Results
| Particulars | Dec 25 | Sept 25 | Jun 25 | Mar 25 | Dec 24 |
|---|---|---|---|---|---|
| Total Revenue (Cr) | 434.34 | 471.83 | 429.08 | 383.89 | 402.45 |
| Net Income (Cr) | -29.79 | -7.93 | -35.79 | -40.39 | -26.39 |
| EPS (₹) | -3.2 | -1 | -3.94 | 0 | -3.08 |
Annual Profit & Loss
| Particulars | 2025 | 2024 | 2023 | 2022 | 1970 |
|---|---|---|---|---|---|
| Total Revenue (Cr) | 1,641.29 | 1,788.22 | 1,640.05 | 1,503.74 | 0 |
| Operating Exp (Cr) | 1,153.57 | 1,063.26 | 903.1 | 803.91 | 0 |
| Net Income (Cr) | -73.74 | 98.46 | 142.25 | 154.8 | 0 |
| EPS (₹) | -8 | 10.68 | 15.44 | 16.8 | 0 |
Balance Sheet
| Particulars | Dec 25 | Sept 25 | Jun 25 | Mar 25 | Dec 24 |
|---|---|---|---|---|---|
| Total Assets (Cr) | - | 2,508.02 | - | 2,429.91 | - |
| Total Liabilities (Cr) | - | 1,533.71 | - | 1,411.54 | - |
| Total Equity (Cr) | - | 979.77 | - | 1,022 | - |
Key Ratios Fundamentals
Valuation
Profitability
Liquidity & Debt
Price Statistics
Pattern Unavailable
Detailed shareholding breakdown is not currently provided by the exchange.